| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 774-781, Copyright © 1994 by Endocrine Society
ARTICLES |
H Kawaguchi, T Kurokawa, K Hanada, Y Hiyama, M Tamura, E Ogata and T Matsumoto
Department of Orthopedic Surgery, University of Tokyo School of Medicine, Japan.
The effect of local application of recombinant human basic fibroblast growth factor (rhbFGF) on fracture repair was examined using normal rats and streptozotocin-diabetic rats with impaired repairing ability. Immediately after fracturing the fibula, rhbFGF was applied by a single injection to the fracture site. Application of rhbFGF increased the volume and mineral content of callus in a dose-dependent manner in both normal and diabetic rats, and callus formation of diabetic rats was stimulated to levels similar to those in nontreated normal rats. The marked effect of rhbFGF on fracture repair was associated with an improvement in the mechanical properties of the healing fibula in both normal and diabetic rats. Immunohistochemical staining showed that endogenous bFGF was widely distributed in normal rats 1 and 3 weeks after fracture, especially in the soft callus and periosteum, whereas much less bFGF was detected in diabetic rats. Insulin treatment of diabetic rats restored the immunostaining for bFGF. These results demonstrate that bFGF is expressed during the early stage of fracture repair, and that the impaired fracture-repairing ability in diabetic rats is associated with reduced expression of bFGF at the fracture site. A single application of bFGF immediately after fracture not only facilitates the repair process in normal rats, but also recovers the impaired repairing ability in diabetic rats. These results suggest that local application of bFGF may facilitate bone union in patients with impaired as well as normal repairing ability.
This article has been cited by other articles:
 |
|
 |
|
  Z.S. AI-Aql, A.S. Alagl, D.T. Graves, L.C. Gerstenfeld, and T.A. Einhorn Molecular Mechanisms Controlling Bone Formation during Fracture Healing and Distraction Osteogenesis Journal of Dental Research, February 1, 2008; 87(2): 107 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Goldhahn, B. Mitlak, P. Aspenberg, J. A. Kanis, R. Rizzoli, J.-Y. Reginster, and the GREES (Group for the Respect of Ethics and Exc Critical Issues in Translational and Clinical Research for the Study of New Technologies to Enhance Bone Repair J. Bone Joint Surg. Am., February 1, 2008; 90(Supplement_1): 43 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. O'Loughlin, S. Morr, L. Bogunovic, A. D. Kim, B. Park, and J. M. Lane Selection and Development of Preclinical Models in Fracture-Healing Research J. Bone Joint Surg. Am., February 1, 2008; 90(Supplement_1): 79 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Ishii, H. Mizuta, A. Sei, J. Hirose, S. Kudo, and Y. Hiraki Healing of full-thickness defects of the articular cartilage in rabbits using fibroblast growth factor-2 and a fibrin sealant J Bone Joint Surg Br, May 1, 2007; 89-B(5): 693 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nakae, H. Kamiya, K. Naruse, N. Horio, Y. Ito, R. Mizubayashi, Y. Hamada, E. Nakashima, N. Akiyama, Y. Kobayashi, et al. Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes, May 1, 2006; 55(5): 1470 - 1477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.T. Graves, R. Liu, M. Alikhani, H. Al-Mashat, and P.C. Trackman Diabetes-enhanced Inflammation and Apoptosis--Impact on Periodontal Pathology Journal of Dental Research, January 1, 2006; 85(1): 15 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Kugimiya, H. Kawaguchi, S. Kamekura, H. Chikuda, S. Ohba, F. Yano, N. Ogata, T. Katagiri, Y. Harada, Y. Azuma, et al. Involvement of Endogenous Bone Morphogenetic Protein (BMP) 2 and BMP6 in Bone Formation J. Biol. Chem., October 21, 2005; 280(42): 35704 - 35712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Tang, R.-S. Yang, T.-H. Huang, S.-H. Liu, and W.-M. Fu Enhancement of Fibronectin Fibrillogenesis and Bone Formation by Basic Fibroblast Growth Factor via Protein Kinase C-Dependent Pathway in Rat Osteoblasts Mol. Pharmacol., September 1, 2004; 66(3): 440 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shimoaka, S. Kamekura, H. Chikuda, K. Hoshi, U.-i. Chung, T. Akune, Z. Maruyama, T. Komori, M. Matsumoto, W. Ogawa, et al. Impairment of Bone Healing by Insulin Receptor Substrate-1 Deficiency J. Biol. Chem., April 9, 2004; 279(15): 15314 - 15322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. He, R. Liu, T. Desta, C. Leone, L. C. Gerstenfeld, and D. T. Graves Diabetes Causes Decreased Osteoclastogenesis, Reduced Bone Formation, and Enhanced Apoptosis of Osteoblastic Cells in Bacteria Stimulated Bone Loss Endocrinology, January 1, 2004; 145(1): 447 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Colnot, Z. Thompson, T. Miclau, Z. Werb, and J. A. Helms Altered fracture repair in the absence of MMP9 Development, September 1, 2003; 130(17): 4123 - 4133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Einhorn, R. J Majeska, A. Mohaideen, E. M. Kagel, M. L. Bouxsein, T. J. Turek, and J. M. Wozney A Single Percutaneous Injection of Recombinant Human Bone Morphogenetic Protein-2 Accelerates Fracture Repair J. Bone Joint Surg. Am., August 1, 2003; 85(8): 1425 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lu, D. Kraut, L. C. Gerstenfeld, and D. T. Graves Diabetes Interferes with the Bone Formation by Affecting the Expression of Transcription Factors that Regulate Osteoblast Differentiation Endocrinology, January 1, 2003; 144(1): 346 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shimoaka, T. Ogasawara, A. Yonamine, D. Chikazu, H. Kawano, K. Nakamura, N. Itoh, and H. Kawaguchi Regulation of Osteoblast, Chondrocyte, and Osteoclast Functions by Fibroblast Growth Factor (FGF)-18 in Comparison with FGF-2 and FGF-10 J. Biol. Chem., February 22, 2002; 277(9): 7493 - 7500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Takayama, S. Murakami, Y. Shimabukuro, M. Kitamura, and H. Okada Periodontal Regeneration by FGF-2 (bFGF) in Primate Models Journal of Dental Research, December 1, 2001; 80(12): 2075 - 2079. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Iwakura, Y. Tabata, N. Tamura, K. Doi, K. Nishimura, T. Nakamura, Y. Shimizu, M. Fujita, and M. Komeda Gelatin Sheet Incorporating Basic Fibroblast Growth Factor Enhances Healing of Devascularized Sternum in Diabetic Rats Circulation, September 18, 2001; 104 (2009): I-325 - I-329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Bouxsein, T. J. Turek, C. A. Blake, D. D'Augusta, X. Li, M. Stevens, H. J. Seeherman, and J. M. Wozney Recombinant Human Bone Morphogenetic Protein-2 Accelerates Healing in a Rabbit Ulnar Osteotomy Model J. Bone Joint Surg. Am., August 1, 2001; 83(8): 1219 - 1230. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Kawaguchi, K. Nakamura, Y. Tabata, Y. Ikada, I. Aoyama, J. Anzai, T. Nakamura, Y. Hiyama, and M. Tamura Acceleration of Fracture Healing in Nonhuman Primates by Fibroblast Growth Factor-2 J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 875 - 880. [Abstract] [Full Text]
|
|
|
|
 |
|
 Md. Muniruzzaman, Y. Tabata, and Y. Ikada Physicochemical Properties of Basic Fibroblast Growth Factor-Gelatin Complex Journal of Bioactive and Compatible Polymers, September 1, 2000; 15(5): 365 - 375. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Notoya, H. Nagai, T. Oda, M. Gotoh, T. Hoshino, H. Muranishi, S. Taketomi, T. Sohda, and H. Makino Enhancement of Osteogenesis In Vitro and In Vivo by a Novel Osteoblast Differentiation Promoting Compound, TAK-778 J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1054 - 1064. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. Manabe, H. Oda, K. Nakamura, Y. Kuga, S. Uchida, and H. Kawaguchi Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients Rheumatology, August 1, 1999; 38(8): 714 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Blanquaert, A. M. Delany, and E. Canalis Fibroblast Growth Factor-2 Induces Hepatocyte Growth Factor/Scatter Factor Expression in Osteoblasts Endocrinology, March 1, 1999; 140(3): 1069 - 1074. [Abstract] [Full Text]
|
|
|
|
|
|
T. Kimoto, R. Hosokawa, T. Kubo, M. Maeda, A. Sano, and Y. Akagawa Continuous Administration of Basic Fibroblast Growth Factor (FGF-2) Accelerates Bone Induction on Rat Calvaria-- An Application of a New Drug Delivery System Journal of Dental Research, December 1, 1998; 77(12): 1965 - 1969. [Abstract] [PDF]
|
|
|
|
|
|
A. M. Delany and E. Canalis Dual Regulation of Stromelysin-3 by Fibroblast Growth Factor-2 in Murine Osteoblasts J. Biol. Chem., June 26, 1998; 273(26): 16595 - 16600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Delany and E. Canalis Basic fibroblast growth factor destabilizes osteonectin mRNA in osteoblasts Am J Physiol Cell Physiol, March 1, 1998; 274(3): C734 - C740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nakanishi, N. Nagaya, T. Yoshimatsu, T. Hanagiri, and K. Yasumoto OPTIMAL DOSE OF BASIC FIBROBLAST GROWTH FACTOR FOR LONG-SEGMENT ORTHOTOPIC TRACHEAL AUTOGRAFTS J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 26 - 36. [Abstract] [Full Text]
|
|
|
|
|
|
S. B. TRIPPEL, R. D. COUTTS, T. A. EINHORN, G. R. MUNDY, and R. G. ROSENFELD Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Growth Factors as Therapeutic Agents*{{dagger}} J. Bone Joint Surg. Am., August 1, 1996; 78(8): 1272 - 86. [Full Text]
|
|
|
|
|
|
D. Chikazu, Y. Hakeda, N. Ogata, K. Nemoto, A. Itabashi, T. Takato, M. Kumegawa, K. Nakamura, and H. Kawaguchi Fibroblast Growth Factor (FGF)-2 Directly Stimulates Mature Osteoclast Function through Activation of FGF Receptor 1 and p42/p44 MAP Kinase J. Biol. Chem., September 29, 2000; 275(40): 31444 - 31450. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
